上海莼试生物技术有限公司
   
菜单 Close 公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 产品展厅 >抗体 >磷酸化原癌基因c-Raf抗体品牌
产品展厅
磷酸化原癌基因c-Raf抗体品牌
  • 品牌:上海莼试
  • 产地:进口、国产
  • 货号:CS11179
  • 发布日期: 2019-01-09
  • 更新日期: 2024-11-26
产品详请
产地 进口、国产
品牌 上海莼试
保存条件 Store at -20 °C
货号 CS11179
应用范围 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS编号
抗体名 Anti-phospho-c-Raf(Ser338)
克隆性
靶点 详见说明书
适应物种 详见说明书
形态 详见说明书
宿主 详见说明书
亚型 IgG
标识物 详见说明书
浓度 1mg/1ml%
免疫原 KLH conjugated synthesised phosphopeptide derived from human c-Raf around the phosphorylation site of Ser338

技术外包服务:

磷酸化原癌基因c-Raf抗体品牌 分子生物学:质粒抽提、PCRQ-PCRRT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等

蛋白工程:原核、哺乳动物蛋白表达系统等

病毒包装:腺病毒、慢病毒等

抗体工程:磁珠分选、病理染色、WBELISAIPIFIHCFACSConfocal等等

细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

实验流程:

磷酸化原癌基因c-Raf抗体品牌 英文名称  Anti-phospho-c-Raf(Ser338)

中文名称  磷酸化原癌基因c-Raf抗体品牌 

     RAF1(phospho S338); Raf1(Phospho-Ser338); RAF1; murine leukemia viral (v-raf-1) oncogene homolog 1 (3611-MSV); v-raf-1 murine leukemia viral oncogene homolog 1; cRaf; C-RAF; proto-oncogene c-RAF; 6430402F14Rik; AA990557; BB129353; c-Raf; Craf1; D830050J10Rik; MGC102375; Raf-1; Raf 1; v-Raf; c Raf; Craf 1 transforming gene; Craf1 transforming gene; EC 2.7.11.1; Murine sarcoma 3611 oncogene 1; RAF; Raf proto oncogene serine/threonine protein kinase; vraf1 murine leukemia viral oncogene homolog 1; c-Raf.

产品属性:

      1mg/1ml

  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep

产品类型   一抗 磷酸化抗体  

研究领域     免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 73kDa 

       Lyophilized or Liquid

  KLH conjugated synthesised phosphopeptide derived from human c-Raf around the phosphorylation site of Ser338

      IgG

纯化方法   affinity purified by Protein A

   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化原癌基因c-Raf抗体品牌 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蜡切片需做抗原修复) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 The Raf family of serine/threonine specific kinases is comprised of three members (aRaf, bRaf, and cRaf) that play a critical role in regulating cell growth and differentiation, and couple growth factor receptor stimulation to nuclear transcription factors via the Ras/mitogen activated protein kinase (MAPK) pathway. cRaf kinase (also known as Raf1) is a small GTPase like kinase of 73 kDa, and is a signal transducer of multiple extracellular stimuli that is regulated by several pathways, and that once activated, phosphorylates MEK which in turn phosphorylates ERK. Raf1 is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. It is part of the Ras dependent signaling pathway from receptors to the nucleus.

Function : Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. [CATALYTIC ACTIVITY] ATP + a protein = ADP + a phosphoprotein.

Subunit : Monomer. Homodimer. Heterodimerizes with BRAF and this heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer. Forms a multiprotein complex with Ras (M-Ras/MRAS), SHOC2 and protein phosphatase 1 (PPP1CA, PPP1CB and PPP1CC). Interacts with Ras proteins; the interaction is antagonized by RIN1. Weakly interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with BRAF, a ternary complex inhibited by GNAI1 (By similarity). Interacts with STK3/MST2; the interaction inhibits its pro-apoptotic activity. Interacts (when phosphorylated at Ser-259) with YWHAZ (unphosphorylated at 'Thr-232'). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (By similarity). Interacts with MAP3K5/ASF1 (via N-terminus) and this interaction inhibits the proapoptotic function of MAP3K5/ASK1. Interacts with PAK1 (via kinase domain). The phosphorylated form interacts with PIN1. The Ser-338 and Ser-339 phosphorylated form (by PAK1) interacts with BCL2. Interacts with PEBP1/RKIP and this interaction is enhanced if RAF1 is phosphorylated on residues Ser-338, Ser-339, Tyr-340 and Tyr-341. Interacts with ADCY2, ADCY5, ADCY6, DGKH, RCAN1/DSCR1, ROCK2, PPP1R12A, PKB/AKT1, PPP2CA, PPP2R1B, SPRY2, SPRY4, CNKSR1/CNK1, KSR2 and PHB/prohibitin.

Subcellular Location : Cytoplasm. Cell membrane. Mitochondrion. Nucleus. Note=Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus.

Tissue Specificity : In skeletal muscle, isoform 1 is more abundant than isoform 2. [PTM] Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK7/PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization.

DISEASE : Defects in RAF1 are the cause of Noonan syndrome type 5 (NS5) [MIM:611553]. Noonan syndrome (NS) is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. It is a genetically heterogeneous and relatively common syndrome, with an estimated incidence of 1 in 1000-2500 live births.

Defects in RAF1 are the cause of LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554]. LEOPARD syndrome is an autosomal dominant disorder allelic with Noonan syndrome. The acronym LEOPARD stands for lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness.

Similarity : Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.

Contains 1 phorbol-ester/DAG-type zinc finger.

Contains 1 protein kinase domain.

Contains 1 RBD (Ras-binding) domain.

Database links : UniProtKB/Swiss-Prot: P04049.1

全、新、优、品、好四大特点:

磷酸化原癌基因c-Raf抗体品牌 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。

新:产品更新速度较快,基本上每周都有新产品出现。

优:产品质量好,投诉比较少。

好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

正在热销的相关产品:

LN (laminin) 层粘连蛋白(多肽抗原)Multi-class antibodies规格: 0.5mg

Anti-ALK/CD246 间变型激酶抗体Multi-class antibodies规格: 0.2ml

Rhesus antibody Rh phospho-c-Abl(Tyr251) 磷酸化非受体酪氨酸激酶c-Abl抗体 规格 0.1ml

低背景抗体稀释液 10ml/100ml pH 7.6

VWCE 英文名称: VWCE抗体 0.2ml

phospho-DAXX (Ser495) 英文名称: 磷酸化Fas相关死亡结构域蛋白抗体 0.1ml

Anti-ALK/CD246 间变型激酶抗体Multi-class antibodies规格: 0.2ml

Anti-Phospho-delta Opioid Receptor (Ser363) /FITC 荧光素标记磷酸化D型受体抗体IgGMulti-class antibodies规格: 0.2ml

Rabbit Anti-mouse IgG/HRP 辣根过氧化物酶标记兔抗小鼠IgGMulti-class antibodies规格: 0.1ml

c-erbB-2抗体 Anti-C-erbB-2 0.1ml

Rabbit Anti-horse IgM/Cy3 Cy3标记的兔抗马IgM 0.1ml

FABPB 英文名称: 脑型脂肪酸结合蛋白抗体 0.2ml

Rhesus antibody Rh PKMYT1 髓鞘转录因子1激酶抗体 规格 0.1ml

Rabbit Anti-mouse IgG/HRP 辣根过氧化物酶标记兔抗小鼠IgGMulti-class antibodies规格: 0.1ml

SEPT6 英文名称: 细胞分化蛋白SEPT6抗体 0.2ml

EML3 英文名称: 微管相关蛋白样蛋白3抗体 0.2ml

组织蛋白酶K抗体 Anti-cath-K/CK 0.1ml

Anti-UG/FITC 荧光素标记子宫珠蛋白抗体IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh Phospho-Histone H3 (Thr3) 磷酸化组蛋白H3抗体 规格 0.1ml

CCR-7(CC chemokine receptor 7) CC趋化因子受体7(多肽)Multi-class antibodies规格: 0.5mg

rCSC, 大鼠心肌细胞

4179 长尾绿猴胚胎细胞

IL1RL1 Others Human 人 IL1RL1 / ST2 ( isoform A ) 人细胞裂解液 (阳性对照)

CL-0271D283 Med(人脑髓母细胞瘤细胞)5×106cells/瓶×2

人成纤维细胞cDNAHCF cDNA

人APP-PS1双基因转染细胞株(HEK293);APP-PS1 人支持细胞完全培养基 100mL

CL-0151MDA-MB-435S(人导管癌细胞)5×106cells/瓶×2

CD3E Others Cynomolgus 食蟹猴 CD3e / CD3 epsilon 人细胞裂解液 (阳性对照)

小鼠肝动脉内皮细胞完全培养基 100mL

HCAEC人内皮细胞 HCAEC in human coronary artery endothelial cells ECM(Sicencell Cat#1001)

IL11 Protein Human 重组人 IL11 / Ierleukin 11 / IL-11 蛋白

RKO-E6(人转基因细胞) 5×106cells/瓶×2 Jecket(细胞)

磷酸化原癌基因c-Raf抗体品牌 rCSC, 大鼠心肌细胞

4179 长尾绿猴胚胎细胞

IL1RL1 Others Human IL1RL1 / ST2 ( isoform A ) 人细胞裂解液 (阳性对照)

CL-0271D283 Med(人脑髓母细胞瘤细胞)5×106cells/瓶×2

人成纤维细胞cDNAHCF cDNA

APP-PS1双基因转染细胞株(HEK293);APP-PS1 人支持细胞完全培养基 100mL


联系方式
手机:13585831301
Q Q: